Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H39N5 |
| Molecular Weight | 409.6107 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C(NCC1=NC=CC=C1)C2=CC=C(CN3CCNCCCCCCCNCC3)C=C2
InChI
InChIKey=AVMFPLAFTONVSZ-UHFFFAOYSA-N
InChI=1S/C25H39N5/c1-2-5-13-26-16-18-30(19-17-27-14-6-3-1)22-24-11-9-23(10-12-24)20-28-21-25-8-4-7-15-29-25/h4,7-12,15,26-28H,1-3,5-6,13-14,16-22H2
| Molecular Formula | C25H39N5 |
| Molecular Weight | 409.6107 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication. | 2010-02-11 |
|
| The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization. | 2007-10 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:12:03 GMT 2025
by
admin
on
Mon Mar 31 22:12:03 GMT 2025
|
| Record UNII |
4CX62N12T4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4CX62N12T4
Created by
admin on Mon Mar 31 22:12:03 GMT 2025 , Edited by admin on Mon Mar 31 22:12:03 GMT 2025
|
PRIMARY | |||
|
462935
Created by
admin on Mon Mar 31 22:12:03 GMT 2025 , Edited by admin on Mon Mar 31 22:12:03 GMT 2025
|
PRIMARY | |||
|
255383-00-7
Created by
admin on Mon Mar 31 22:12:03 GMT 2025 , Edited by admin on Mon Mar 31 22:12:03 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
